Special Issue Item
Journal Editorial
Scientific opinions of Scientific/Scientific Panel
Opinion of the Scientific Committee/Scientific Panel
Statement of the Scientific Committee/Scientific Panel
Guidance of the Scientific Committee/Scientific Panel
Statement of EFSA
Guidance of EFSA
Conclusion on pesticides
Reasoned opinion on pesticide
Scientific report of EFSA
Technical Report
Animal health & welfare
Biological hazards
Biological monitoring
Contaminants
Dietary & chemical monitoring
Emerging risks
Feed
GMO
Nutrition
Pesticides
Plant health
Scientific assessment support
Scientific Committee
Scientific cooperation
Relevance
Opinion of the Scientific Panel on Dietetic products, nutrition and allergies [NDA] related to the safety and suitability for particular nutritional use by infants of formula based on whey protein partial hydrolysates with a protein content of at least 1.9 g protein/100 kcal
Wulf Becker, Francesco Branca, Daniel Brasseur, Jean-Louis Bresson, Albert Flynn, Alan A.
Jackson, Pagona Lagiou, Martinus Løvik, Geltrude Mingrone, Bevan Moseley, Andreu Palou,
Hildegard Przyrembel, Seppo Salminen, Stephan Strobel, Henk van den Berg, and Hendrik
van Loveren.
No abstract available
The Panel has been asked to provide a scientific opinion on the suitability for the particular nutritional requirements of infants and young children of an infant formulae and follow-on formulae based on protein partial hydrolysates with a protein content of 1.9 g/100 kcal.
The conclusions of the Panel are as follows:
The formula is as suitable to satisfy the particular nutritional requirements of young infants and as safe as a formula based on hydrolysed whey protein with a higher protein content when fed ad libitum. This conclusion is primarily based upon the growth data of term-infants who were studied between the ages of 8 to 112 days. The nitrogen balance data and the protein status parameters are considered to be supportive of this conclusion. The conclusion on the suitability of the formula with a crude protein content of 1.9 g/100 kcal is specific for this formulation and the protein source it contains. While no data on follow-on formula based on hydrolysed whey protein with a protein content of 1.9 g/100 kcal have been submitted, the Panel considers that a formula with this protein formulation is suitable for use in older infants in conjunction with complementary foods.
Any infant formula with a similar crude protein content but differing in protein quality, protein sources or protein processing needs to be tested in a clinical study and its safety should be documented and assessed.
Recommendations on how to assess the protein quality, sufficiency and suitability in infant formulae have been published. They include a clinical trial of three to four months duration in a group of healthy term infants with a number to provide sufficient statistical power in comparison to an existing infant formula and/or a reference group of breast-fed infants, and starting preferably at or near birth. Data on growth, protein status and on formula intake should be collected.
Infant formula, infant nutrition, protein requirement, partially hydrolysed whey protein, lowprotein formula, growth.
